⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

CAPLIPOINT - Technical Analysis with Chart Patterns & Indicators

Back to List

Rating: 4.3

Last Updated Time : 28 May 26, 07:19 pm

Technical Rating: 4.3

Stock Code CAPLIPOINT Market Cap 15,410 Cr. Current Price 2,027 ₹ High / Low 2,397 ₹
Stock P/E 38.9 Book Value 270 ₹ Dividend Yield 0.30 % ROCE 27.0 %
ROE 21.1 % Face Value 2.00 ₹ DMA 50 1,834 ₹ DMA 200 1,858 ₹
Chg in FII Hold -0.43 % Chg in DII Hold 0.09 % PAT Qtr 110 Cr. PAT Prev Qtr 87.3 Cr.
RSI 65.3 MACD 84.4 Volume 75,208 Avg Vol 1Wk 1,12,772
Low price 1,500 ₹ High price 2,397 ₹ PEG Ratio 2.01 Debt to equity 0.00
52w Index 58.7 % Qtr Profit Var 26.6 % EPS 52.2 ₹ Industry PE 31.6

📊 Chart Patterns & Trend: CAPLIPOINT is in a strong uptrend, trading well above both 50 DMA (1,834 ₹) and 200 DMA (1,858 ₹). Current price (2,027 ₹) is approaching resistance at 2,100–2,150 ₹, with major resistance at 2,397 ₹. Trendlines confirm bullish continuation.

📈 Moving Averages: Price comfortably above both 50 DMA and 200 DMA, showing strong bullish alignment.

📉 RSI: At 65.3, RSI is near overbought territory, signaling strong momentum but caution near resistance.

📈 MACD: Strongly positive (84.4), confirming bullish momentum and trend continuation.

📊 Bollinger Bands: Price is near the upper band, suggesting strong buying pressure but potential short-term pullback.

📊 Volume Trends: Current volume (75,208) is below the 1-week average (1,12,772), showing reduced participation despite bullish price action.

💡 Momentum Signals: Bullish bias. A breakout above 2,100 ₹ could trigger upside toward 2,397 ₹, while support lies near 1,950–1,970 ₹.

🎯 Entry Zone: 1,950–2,000 ₹ (support region).

🎯 Exit Zone: 2,100–2,150 ₹ (resistance region; extended target 2,397 ₹).

📌 Status: Trending upward with strong bullish momentum.

Positive

✔ Strong ROCE (27.0%) and ROE (21.1%).

✔ Debt-free balance sheet (Debt-to-equity: 0.00).

✔ PAT growth (110 Cr. vs 87.3 Cr.) shows earnings momentum.

✔ EPS of 52.2 ₹ supports valuation strength.

Limitation

⚠ High P/E (38.9) compared to industry PE (31.6), suggesting premium valuation.

⚠ RSI near overbought zone (65.3).

⚠ Volume below average, limiting breakout strength.

⚠ PEG ratio of 2.01 indicates growth is priced in.

Company Negative News

⚠ FII holdings declined (-0.43%), showing reduced foreign investor confidence.

Company Positive News

✔ DII holdings increased (+0.09%), signaling domestic institutional support.

✔ Quarterly PAT growth of 26.6% highlights strong profitability.

✔ Consistent dividend payout (0.30% yield).

Industry

🏭 Pharmaceutical sector remains resilient with global demand.

📈 Industry PE (31.6) lower than CAPLIPOINT’s PE (38.9), showing premium valuation for quality fundamentals.

Conclusion

📌 CAPLIPOINT is in a strong uptrend with bullish technicals. Entry near 1,950–2,000 ₹ offers favorable risk-reward, while exits near 2,100–2,150 ₹ are prudent unless momentum drives a breakout toward 2,397 ₹. Long-term investors may hold, while traders should monitor RSI and volume for breakout confirmation.

Would you like me to expand this into a sector overlay analysis comparing peers, or keep it focused on intraday trading signals for sharper entry/exit timing?

Technical Analysis
Fundamental Analysis

NIFTY 50 - Technical Stock Watchlist

NEXT 50 - Technical Stock Watchlist

MIDCAP - Technical Stock Watchlist

SMALLCAP - Technical Stock Watchlist